225 related articles for article (PubMed ID: 11085591)
21. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
[TBL] [Abstract][Full Text] [Related]
22. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
[TBL] [Abstract][Full Text] [Related]
23. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.
Lorson CL; Androphy EJ
Hum Mol Genet; 2000 Jan; 9(2):259-65. PubMed ID: 10607836
[TBL] [Abstract][Full Text] [Related]
24. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
[TBL] [Abstract][Full Text] [Related]
25. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
Cartegni L; Krainer AR
Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
[TBL] [Abstract][Full Text] [Related]
26. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
[TBL] [Abstract][Full Text] [Related]
27. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization.
Zhang HL; Pan F; Hong D; Shenoy SM; Singer RH; Bassell GJ
J Neurosci; 2003 Jul; 23(16):6627-37. PubMed ID: 12878704
[TBL] [Abstract][Full Text] [Related]
28. The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells.
Riessland M; Brichta L; Hahnen E; Wirth B
Hum Genet; 2006 Aug; 120(1):101-10. PubMed ID: 16724231
[TBL] [Abstract][Full Text] [Related]
29. Spinal muscular atrophy: position and functional importance of the branch site preceding SMN exon 7.
Scholl R; Marquis J; Meyer K; Schümperli D
RNA Biol; 2007; 4(1):34-7. PubMed ID: 17585203
[TBL] [Abstract][Full Text] [Related]
30. Robust quantification of the SMN gene copy number by real-time TaqMan PCR.
Gómez-Curet I; Robinson KG; Funanage VL; Crawford TO; Scavina M; Wang W
Neurogenetics; 2007 Nov; 8(4):271-8. PubMed ID: 17647030
[TBL] [Abstract][Full Text] [Related]
31. Induction of full-length survival motor neuron by polyphenol botanical compounds.
Sakla MS; Lorson CL
Hum Genet; 2008 Jan; 122(6):635-43. PubMed ID: 17962980
[TBL] [Abstract][Full Text] [Related]
32. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).
Hofmann Y; Lorson CL; Stamm S; Androphy EJ; Wirth B
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9618-23. PubMed ID: 10931943
[TBL] [Abstract][Full Text] [Related]
33. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
DiMatteo D; Callahan S; Kmiec EB
Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
[TBL] [Abstract][Full Text] [Related]
34. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.
Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L
Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491
[TBL] [Abstract][Full Text] [Related]
35. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
Coady TH; Shababi M; Tullis GE; Lorson CL
Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.
Helmken C; Hofmann Y; Schoenen F; Oprea G; Raschke H; Rudnik-Schöneborn S; Zerres K; Wirth B
Hum Genet; 2003 Dec; 114(1):11-21. PubMed ID: 14520560
[TBL] [Abstract][Full Text] [Related]
37. Analysis of mutations in the tudor domain of the survival motor neuron protein SMN.
Mohaghegh P; Rodrigues NR; Owen N; Ponting CP; Le TT; Burghes AH; Davies KE
Eur J Hum Genet; 1999 Jul; 7(5):519-25. PubMed ID: 10439956
[TBL] [Abstract][Full Text] [Related]
38. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
[TBL] [Abstract][Full Text] [Related]
39. An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy.
Singh NN; Androphy EJ; Singh RN
Biochem Biophys Res Commun; 2004 Mar; 315(2):381-8. PubMed ID: 14766219
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling.
Wirth B; Herz M; Wetter A; Moskau S; Hahnen E; Rudnik-Schöneborn S; Wienker T; Zerres K
Am J Hum Genet; 1999 May; 64(5):1340-56. PubMed ID: 10205265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
